A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults

Clinical trial NCT07233291 · RECRUITING

Trial details

NCT number: NCT07233291
Sponsor: Ahmed Ibrahim
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis (PsO)

Start date: 2025-08-20
Primary completion: 2026-02-28
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.